| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.1M | -4.8% | -28.7% |
| SG&A Expense | $967K | -3.3% | +24.5% |
| Operating Income | -$6.0M | +4.6% | +23.5% |
| Pre-tax Income | -$5.9M | -241.8% | -18.0% |
| Income Tax | $102K | +264.3% | +1033.3% |
| Net Income | -$6.0M | -242.1% | -19.8% |
| EPS (Basic) | -$0.20 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $147.4M | -3.6% | -19.5% |
| Accounts Receivable | $450K | -6.3% | -38.4% |
| Current Assets | $149.0M | -3.8% | -19.5% |
| Total Assets | $172.4M | -3.5% | -17.8% |
| Current Liabilities | $3.6M | -7.6% | -77.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.0M | — | — |
| Capital Expenditures | $255K | — | — |
| Investing Cash Flow | -$255K | — | — |
| Financing Cash Flow | -$10.3M | — | — |
| Free Cash Flow | -$17.2M | — | — |
| -233.3% |
| -25.0% |
| $5.3M |
| -4.9% |
| -69.9% |
| Stockholders' Equity | $167.1M | -3.5% | -13.0% |